REVENUES (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
|---|
| REVENUES |
|
| Schedule of revenues disaggregated by category |
Revenues disaggregated by category were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Product sales: |
|
|
|
|
|
|
|
|
|
|
|
|
Gross product sales |
|
$ |
48,980 |
|
$ |
33,456 |
|
$ |
87,406 |
|
$ |
66,654 |
Discounts and allowances |
|
|
(15,530) |
|
|
(9,575) |
|
|
(27,953) |
|
|
(19,028) |
Total product sales, net |
|
|
33,450 |
|
|
23,881 |
|
|
59,453 |
|
|
47,626 |
Revenues from collaborations: |
|
|
|
|
|
|
|
|
|
|
|
|
Delivery of drug supplies, royalty and others |
|
|
3,391 |
|
|
2,005 |
|
|
6,922 |
|
|
4,330 |
Total revenues from collaborations |
|
|
3,391 |
|
|
2,005 |
|
|
6,922 |
|
|
4,330 |
Government contracts |
|
|
— |
|
|
1,000 |
|
|
— |
|
|
1,000 |
Total revenues |
|
$ |
36,841 |
|
$ |
26,886 |
|
$ |
66,375 |
|
$ |
52,956 |
|
| Schedule of product revenue allowance and reserve categories |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2024 |
|
$ |
8,236 |
|
$ |
3,517 |
|
$ |
3,931 |
|
$ |
15,684 |
Provision related to current period sales |
|
|
21,770 |
|
|
5,259 |
|
|
522 |
|
|
27,551 |
Credit or payments made during the period |
|
|
(20,165) |
|
|
(4,441) |
|
|
(82) |
|
|
(24,688) |
Balance as of June 30, 2024 |
|
$ |
9,841 |
|
$ |
4,335 |
|
$ |
4,371 |
|
$ |
18,547 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chargebacks, |
|
Government |
|
|
|
|
|
|
|
|
Discounts and |
|
and Other |
|
|
|
|
|
|
|
|
Fees |
|
Rebates |
|
Returns |
|
Total |
Balance as of January 1, 2023 |
|
$ |
6,213 |
|
$ |
2,636 |
|
$ |
3,296 |
|
$ |
12,145 |
Provision related to current period sales |
|
|
14,439 |
|
|
3,725 |
|
|
395 |
|
|
18,559 |
Credit or payments made during the period |
|
|
(13,139) |
|
|
(3,765) |
|
|
(116) |
|
|
(17,020) |
Balance as of June 30, 2023 |
|
$ |
7,513 |
|
$ |
2,596 |
|
$ |
3,575 |
|
$ |
13,684 |
|
| Schedule of revenues from product sales disaggregated by customers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
2024 |
|
2023 |
|
|
2024 |
|
2023 |
McKesson Corporation |
|
|
49% |
|
|
44% |
|
|
|
46% |
|
|
45% |
Cardinal Health, Inc. |
|
|
21% |
|
|
28% |
|
|
|
22% |
|
|
26% |
Cencora Inc. (formerly ASD Healthcare) |
|
|
20% |
|
|
19% |
|
|
|
21% |
|
|
21% |
|